Download Adobe Reader PDF    Resize font:
Policy and Advocacy

Arthritis Australia advocates to government, business, industry and community leaders to improve care, management, support and quality of life for people with arthritis. In addition to developing a consumer led, proactive policy and advocacy agenda, we participate in government consultations and prepare submissions to government agencies on a range of issues affecting people with arthritis.

 

Medical Research Future Fund

Arthritis Australia is advocating for increased government research funding for arthritis and musculoskeletal conditions from the Medical Research Future Fund (MRFF). The MRFF was recently established by the Australian Government to boost strategic investment in medical research.

 

Current government research funding for arthritis and musculoskeletal conditions is disproportionately low relative to the disease burden and cost of these conditions.  Strategic investment from the MRFF will boost research capacity to achieve a quantum leap in the quality and utility of research in the musculoskeletal field. 

 

Click on the links below to view
 

   Boosting musculoskeletal research through strategic co-investment with the Medical Research Future Fund
 

   MSK Burden of musculoskeletal conditions MRFF Submission
 

   Arthritis Australia MRFF Priorities submission

 

 

Submission to the Therapeutic Goods Administration on Regulation of autologous cell and tissue products

Arthritis Australia and the Australian Rheumatology Association made a submission to the Therapeutic Goods Administration’s review of regulatory arrangements for treatments which use a person’s own cells or tissues. Our interest in this area relates in particular to the use of stem cell therapies to treat osteoarthritis, which we recommend should be subject to more stringent regulation.

Click on the links below to view

   Submission to the Therapeutic Goods Administration on Regulation of autologous cell and tissue products

 


Submissions to Government


  Therapeutic Goods Administration: Packaging and labelling of medicines

  Therapeutic Goods Administration: Evidence for listed medicines

   Review of Health and Medical Research in Australia

   Response to the  Productivity Commission’s recommendations in its inquiry report Caring for Older Australians

   Arthritis Australia submission on NDIS eligibility and support statement
 

 




Reviewed and updated February 2017

 
 
Proud partner of:
 

corner-piece